HYPERRHO S/D FULL DOSE- rho(d) immune globulin (human) solution

Grifols

HyperRHO S/D Full Dose is recommended for the prevention of Rh hemolytic disease of the newborn by its administration to the Rh (D) negative mother within 72 hours after birth of an Rh (D) positive infant,(12) providing the following criteria are met:

1. The mother must be Rh (D) negative and must not already be sensitized to the Rh (D) factor.
2. Her child must be Rh (D) positive, and should have a negative direct antiglobulin test (see PRECAUTIONS).

If HyperRHO S/D Full Dose is administered antepartum, it is essential that the mother receive another dose of HyperRHO S/D Full Dose after delivery of an Rh (D) positive infant.

If the father can be determined to be Rh (D) negative, HyperRHO S/D Full Dose need not be given.

HyperRHO S/D Full Dose should be administered within 72 hours to all nonimmunized Rh (D) negative women who have undergone spontaneous or induced abortion, following ruptured tubal pregnancy, amniocentesis or abdominal trauma unless the blood group of the fetus or the father is known to be Rh (D) negative.(7,8) If the fetal blood group cannot be determined, one must assume that it is Rh (D) positive,(2) and HyperRHO S/D Full Dose should be administered to the mother.

Store at 2–8°C (36–46°F). Do not freeze.